{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:55:37Z","timestamp":1783691737695,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.biocel.2022.106358","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T21:12:22Z","timestamp":1672175542000},"page":"106358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["PARP1 controls the transcription of CD24 by ADP-ribosylating the RNA helicase DDX5 in pancreatic cancer"],"prefix":"10.1016","volume":"155","author":[{"given":"Kang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manxiong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanneng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weitao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2022.106358_bib1","first-page":"14","article-title":"Pharmacologic induction of BRCAness in BRCA-proficient cancers: expanding PARP inhibitor Use","author":"Abbotts","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biocel.2022.106358_bib2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.33249","article-title":"Novel insights into the function of CD24: a driving force in cancer","volume":"148","author":"Altevogt","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biocel.2022.106358_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/BCJ20210722","article-title":"Reconstitution of the DTX3L-PARP9 complex reveals determinants for high-affinity heterodimerization and multimeric assembly","volume":"479","author":"Ashok","year":"2022","journal-title":"Biochem. J."},{"key":"10.1016\/j.biocel.2022.106358_bib4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1053\/j.ackd.2021.09.007","article-title":"Tumor lysis syndrome","volume":"28","author":"Barbar","year":"2021","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.biocel.2022.106358_bib5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2022.106358_bib6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ygyno.2017.10.003","article-title":"PARP inhibitors: clinical utility and possibilities of overcoming resistance","volume":"147","author":"Bitler","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biocel.2022.106358_bib7","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1111\/febs.13737","article-title":"New directions in poly (ADP-ribose) polymerase biology","volume":"283","author":"Bock","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.biocel.2022.106358_bib8","first-page":"14","article-title":"BRCA mutations in ovarian and prostate cancer: bench to bedside","author":"Boussios","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biocel.2022.106358_bib9","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.3748\/wjg.v22.i31.6987","article-title":"FOLFIRINOX and translational studies: towards personalized therapy in pancreatic cancer","volume":"22","author":"Caparello","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biocel.2022.106358_bib10","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1126\/science.1168988","article-title":"CD24 and Siglec-10 selectively repress tissue damage-induced immune responses","volume":"323","author":"Chen","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.biocel.2022.106358_bib11","article-title":"Harnessing and enhancing macrophage phagocytosis for cancer therapy","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biocel.2022.106358_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/1878-0261.13285","article-title":"DNA repair as a shared hallmark in cancer and ageing","author":"Clarke","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.biocel.2022.106358_bib13","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/cncr.31551","article-title":"Annual report to the nation on the status of cancer, part I: National cancer statistics","volume":"124","author":"Cronin","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.biocel.2022.106358_bib14","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/tox.23500","article-title":"Circular RNA dehydrodolichyl diphosphate synthase facilitated triple-negative breast cancer progression via miR-362-3p\/DDX5 axis","volume":"37","author":"Cui","year":"2022","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.biocel.2022.106358_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0889-8529(18)30258-5","article-title":"Tumor secretion of growth factors","volume":"20","author":"Daughaday","year":"1991","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.biocel.2022.106358_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biocel.2022.106358_bib17","first-page":"14","article-title":"BRCA-mutated pancreatic cancer: from discovery to novel treatment paradigms","author":"Devico Marciano","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biocel.2022.106358_bib18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1158\/2326-6066.CIR-18-0071","article-title":"PARP1 suppresses the transcription of PD-L1 by poly (ADP-ribosyl)ating STAT3","volume":"7","author":"Ding","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.biocel.2022.106358_bib19","first-page":"10","article-title":"CD24 is a potential immunotherapeutic target for mantle cell lymphoma","author":"Freile","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.biocel.2022.106358_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41556-022-00872-5","article-title":"Poly (ADP-ribosylation) of P-TEFb by PARP1 disrupts phase separation to inhibit global transcription after DNA damage","volume":"24","author":"Fu","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biocel.2022.106358_bib21","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1093\/nar\/gkl460","article-title":"DExD\/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulation","volume":"34","author":"Fuller-Pace","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biocel.2022.106358_bib22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2022.106358_bib23","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.annonc.2020.09.018","article-title":"Survival benefits of PARP inhibitors in advanced breast cancer: a mirage?","volume":"31","author":"Grinda","year":"2020","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.biocel.2022.106358_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1101\/gad.291518.116","article-title":"PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes","volume":"31","author":"Gupte","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.biocel.2022.106358_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.eururo.2021.09.024","article-title":"The Significance of PARP1 as a biomarker for Predicting the Response to PD-L1 Blockade in Patients with PBRM1-mutated clear cell renal cell carcinoma","volume":"81","author":"Hagiwara","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biocel.2022.106358_bib26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-022-01042-7","article-title":"Targeting signaling pathways in prostate cancer: mechanisms and clinical trials","volume":"7","author":"He","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biocel.2022.106358_bib27","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.22.01063","article-title":"Biomarkers for systemic therapy in metastatic breast cancer: ASCO guideline update","author":"Henry","year":"2022","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.biocel.2022.106358_bib28","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/cjp2.266","article-title":"CD24 is a surrogate for 'immune-cold' phenotype in aggressive large B-cell lymphoma","volume":"8","author":"Higashi","year":"2022","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.biocel.2022.106358_bib29","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome","volume":"364","author":"Howard","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biocel.2022.106358_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.omto.2022.03.009","article-title":"CAR T cell therapy and the tumor microenvironment: current challenges and opportunities","volume":"25","author":"Kankeu Fonkoua","year":"2022","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.biocel.2022.106358_bib31","doi-asserted-by":"crossref","first-page":"12975","DOI":"10.1074\/jbc.M111.321828","article-title":"CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation","volume":"287","author":"Kashima","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biocel.2022.106358_bib32","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.molcel.2019.06.020","article-title":"Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21","volume":"75","author":"Kim","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biocel.2022.106358_bib33","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jamaoncol.2019.1048","article-title":"Single-Arm phases 1 and 2 trial of niraparib in combination with pembrolizumab in patients with recurrent platinum-resistant ovarian carcinoma","volume":"5","author":"Konstantinopoulos","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.biocel.2022.106358_bib34","first-page":"23","article-title":"The molecular mechanisms of actions, effects, and clinical implications of PARP inhibitors in epithelial ovarian cancers: a systematic review","author":"Lau","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biocel.2022.106358_bib35","first-page":"20","article-title":"Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: a phase I study","volume":"169","author":"Lau","year":"2022"},{"key":"10.1016\/j.biocel.2022.106358_bib36","article-title":"DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer","author":"Le","year":"2022","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.biocel.2022.106358_bib37","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/s41590-020-0761-y","article-title":"Regulation and modulation of antitumor immunity in pancreatic cancer","volume":"21","author":"Leinwand","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biocel.2022.106358_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110127","article-title":"PAK5 promotes RNA helicase DDX5 sumoylation and miRNA-10b processing in a kinase-dependent manner in breast cancer","volume":"37","author":"Li","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.biocel.2022.106358_bib39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.it.2009.09.006","article-title":"CD24-Siglec G\/10 discriminates danger- from pathogen-associated molecular patterns","volume":"30","author":"Liu","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biocel.2022.106358_bib40","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1038\/s41467-022-32166-7","article-title":"Poly (ADP) ribose polymerase promotes DNA polymerase theta-mediated end joining by activation of end resection","volume":"13","author":"Luedeman","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biocel.2022.106358_bib41","doi-asserted-by":"crossref","first-page":"28675","DOI":"10.1074\/jbc.M115.661611","article-title":"Poly (ADP-ribosyl)ation of FOXP3 protein mediated by PARP-1 protein regulates the function of regulatory T cells","volume":"290","author":"Luo","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biocel.2022.106358_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114301","article-title":"Modulating tumor physical microenvironment for fueling CAR-T cell therapy","volume":"185","author":"Luo","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biocel.2022.106358_bib43","doi-asserted-by":"crossref","unstructured":"Martinez F.O. , Analysis of gene expression and gene silencing in human macrophages. Current Protoc. Immunol., 2012; Chapter 14:Unit 14.28.1\u20133.","DOI":"10.1002\/0471142735.im1428s96"},{"key":"10.1016\/j.biocel.2022.106358_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jim.2008.11.019","article-title":"A novel method to determine the engulfment of apoptotic cells by macrophages using pHrodo succinimidyl ester","volume":"342","author":"Miksa","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.biocel.2022.106358_bib45","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.biocel.2022.106358_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00018-022-04235-z","article-title":"Functions of ADP-ribose transferases in the maintenance of telomere integrity","volume":"79","author":"Muoio","year":"2022","journal-title":"Cell. Mol. life Sci. CMLS"},{"key":"10.1016\/j.biocel.2022.106358_bib47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nprot.2006.27","article-title":"Protocol for the fast chromatin immunoprecipitation (ChIP) method","volume":"1","author":"Nelson","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biocel.2022.106358_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41571-020-00452-2","article-title":"PARP inhibitors coming of age","volume":"18","author":"Paluch-Shimon","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biocel.2022.106358_bib49","first-page":"12","article-title":"CD24: A novel target for cancer immunotherapy","author":"Panagiotou","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.biocel.2022.106358_bib50","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.trecan.2021.05.004","article-title":"Development of poly (ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promises","volume":"7","author":"Pham","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.biocel.2022.106358_bib51","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/hon.2668","article-title":"Current understanding of tumor lysis syndrome","volume":"37","author":"Rahmani","year":"2019","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.biocel.2022.106358_bib52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/cncr.33885","article-title":"JASPER: phase 2 trial of first-line niraparib plus pembrolizumab in patients with advanced non-small cell lung cancer","volume":"128","author":"Ramalingam","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.biocel.2022.106358_bib53","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S1470-2045(22)00369-2","article-title":"Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b\/2 trial","volume":"23","author":"Reiss","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biocel.2022.106358_bib54","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.immuni.2017.10.006","article-title":"Tissue-resident macrophages are locally programmed for silent clearance of apoptotic cells","volume":"47","author":"Roberts","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.biocel.2022.106358_bib55","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1200\/JCO.2014.58.8848","article-title":"Poly (ADP-ribose) polymerase inhibitors: recent advances and future development","volume":"33","author":"Scott","year":"2015","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.biocel.2022.106358_bib56","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biocel.2022.106358_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13673","article-title":"seRNA PAM controls skeletal muscle satellite cell proliferation and aging through trans regulation of Timp2 expression synergistically with Ddx5","volume":"21","author":"So","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.biocel.2022.106358_bib58","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaoncol.2019.1029","article-title":"Open-label clinical trial of niraparib combined with pembrolizumab for treatment of advanced or metastatic triple-negative breast cancer","volume":"5","author":"Vinayak","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.biocel.2022.106358_bib59","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.molcel.2022.03.034","article-title":"Cytoplasmic PARP1 links the genome instability to the inhibition of antiviral immunity through PARylating cGAS","volume":"82","author":"Wang","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biocel.2022.106358_bib60","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/cas.12755","article-title":"DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating \u03b2-catenin signaling pathway","volume":"106","author":"Wang","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biocel.2022.106358_bib61","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1101\/gad.182618.111","article-title":"Recognition of the iso-ADP-ribose moiety in poly (ADP-ribose) by WWE domains suggests a general mechanism for poly (ADP-ribosyl)ation-dependent ubiquitination","volume":"26","author":"Wang","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.biocel.2022.106358_bib62","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.ackd.2013.07.001","article-title":"Tumor lysis syndrome: new challenges and recent advances","volume":"21","author":"Wilson","year":"2014","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.biocel.2022.106358_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2022.07.008","article-title":"Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: a bench-to-bedside review","author":"Xiong","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biocel.2022.106358_bib64","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biocel.2022.106358_bib65","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s40425-019-0812-9","article-title":"Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer","volume":"7","author":"Zhang","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biocel.2022.106358_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.102598","article-title":"The CD24 (+) cell subset promotes invasion and metastasis in human osteosarcoma","volume":"51","author":"Zhou","year":"2020","journal-title":"EBioMedicine"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272522002035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272522002035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:23:47Z","timestamp":1761204227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272522002035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":66,"alternative-id":["S1357272522002035"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2022.106358","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PARP1 controls the transcription of CD24 by ADP-ribosylating the RNA helicase DDX5 in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2022.106358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106358"}}